Frailty Assessment in Kidney Transplantation: Insights from a European Survey
Abstract Background Frailty has been identified as an important determinant of adverse transplant-related outcomes; however, its integration into routine kidney transplant practice remains limited. Methods A web-based cross-sectional survey assessing current practice patterns and perceptions on frailty assessments among transplant physicians distributed by The DESCaRTES working group of the European Renal Association. The survey consisted of questions about frailty perceptions and practices both pre- and post-transplant. Results A total of 134 responses (response rate 39.2%) were recorded. Although 98.5% recognized frailty as a risk factor for adverse outcomes, only 6.7% reported routinely performing a standardized frailty assessment in pre-transplant evaluations. Nearly 30% never evaluated frailty, and 24.6% did so only in selected high-risk patients, primarily based on age, comorbidities, or prolonged dialysis duration. Physical function was recognized as the most important component of frailty assessments; however, no single assessment tool was consistently implemented. The main barriers to integrating frailty assessments into clinical practice were lack of trained staff, absence of standardized guidelines, and uncertainty about clinical usefulness. Post-transplant frailty assessments were rarely conducted routinely, despite 74.6% acknowledging their potential value. Conclusions Despite widespread recognition of frailty as a significant determinant influencing transplant outcomes, its routine assessment in clinical practice remains limited across European centers. Variability in assessment tools, lack of guidelines, and insufficient training resources contribute to this gap. Addressing these barriers through targeted education, validation of practical assessment tools, and consensus-driven protocols is essential to support the integration of frailty evaluation into both pre- and post-transplant care.
Authors
- Luuk B. Hilbrands (ORCID: https://orcid.org/0000-0002-4935-9765)
- Rachel Hellemans (ORCID: https://orcid.org/0000-0002-8658-8735)
- Helen Erlandsson (ORCID: https://orcid.org/0000-0003-3898-2575)
- ARZU VELİOĞLU
- Mario Schiffer
- Ilaria Gandolfini
- Annelis De Weerd
- Erol Demir
- Christophe Mariat
Institutions
- Yeditepe University (TR)
- University of Parma (IT)
- Koç University (TR)
- Radboud University Nijmegen (NL)
- University of Antwerp (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Queen Elizabeth Hospital Birmingham (GB)
- Erasmus MC (NL)
- Martin University (US)
- Radboud University Medical Center (NL)
- Karolinska Institutet (SE)
- Universitätsklinikum Erlangen (DE)
- Antwerp University Hospital (BE)
- University Hospitals Parma Medical Center (US)
- Hôpital Nord (FR)
- Comprehensive Cancer Center Erlangen (DE)
- Erasmus MC Cancer Institute (NL)
- Marmara University (TR)
- Université Jean Monnet (FR)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1093/ckj/sfag065
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00